Cite
Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.
MLA
Qiong Zhang, et al. “Induction of Neutralizing Antibodies against SARS-CoV-2 Variants by a Multivalent MRNA-Lipid Nanoparticle Vaccine Encoding SARS-CoV-2/SARS-CoV Spike Protein Receptor-Binding Domains in Mice.” PLoS ONE, vol. 19, no. 4, Jan. 2024, p. e0300524. EBSCOhost, https://doi.org/10.1371/journal.pone.0300524&type=printable.
APA
Qiong Zhang, Shashi Tiwari, Jing Wen, Shaobo Wang, Lingling Wang, Wanyu Li, Lingzhi Zhang, Stephen Rawling, Yong Cheng, Jesse Jokerst, & Tariq M Rana. (2024). Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice. PLoS ONE, 19(4), e0300524. https://doi.org/10.1371/journal.pone.0300524&type=printable
Chicago
Qiong Zhang, Shashi Tiwari, Jing Wen, Shaobo Wang, Lingling Wang, Wanyu Li, Lingzhi Zhang, et al. 2024. “Induction of Neutralizing Antibodies against SARS-CoV-2 Variants by a Multivalent MRNA-Lipid Nanoparticle Vaccine Encoding SARS-CoV-2/SARS-CoV Spike Protein Receptor-Binding Domains in Mice.” PLoS ONE 19 (4): e0300524. doi:10.1371/journal.pone.0300524&type=printable.